COMMUNIQUÉS West-GlobeNewswire

Elevé Cosmetic Surgery Officially Opens in Coral Gables, Accepting a Limited Number of Patients Seeking a Boutique Surgical Experience
24/09/2025
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Elevé Cosmetic Surgery, a new boutique practice in Coral Gables, today announced that it is officially open and accepting a limited number of new patients for facial and [...]
PhenQ Australia Over the Counter | Fast Acting Fat Burner and Appetite Suppressant Australian Launch OTC by PhenQ
23/09/2025
New York City, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Leading natural weight loss pill brand PhenQ today announced the Australian over‑the‑counter launch of its fast‑acting fat burner and appetite suppressant, giving [...]
Ron Schaefer Named President and CEO of Emerald Communities, Emerald Heights, and Heron’s Key
23/09/2025
REDMOND, Wash., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Emerald Communities is proud to announce the appointment of Ron Schaefer as the new President and Chief Executive Officer of Emerald Communities, Emerald Heights, and [...]
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
23/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to present a corporate update at the [...]
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
23/09/2025
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be held September 24, 2025 at 10:30 a.m. ET – CAMBRIDGE, [...]
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
23/09/2025
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting Late Breaking Abstract titled EFFICACY OF OBEFAZIMOD [...]
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
23/09/2025
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
23/09/2025
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
23/09/2025
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health [...]
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient
23/09/2025
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient De nouveaux centres à Dubaï, au Koweït et à Abu Dhabi après la première implantation de Genio® dans la région au début de l'année 2025 Mont [...]
Nyxoah Provides an Update on Expanded Middle East Presence
23/09/2025
Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025 Mont-Saint-Guibert, Belgium – September 23, 2025, 10: [...]
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
23/09/2025
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes NANTES, France – 23 septembre 2025, 22 h 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) prend acte de la décision [...]
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
23/09/2025
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) acknowledges the decision [...]
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
23/09/2025
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
23/09/2025
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company’s supplemental New [...]
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/09/2025
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September [...]
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
23/09/2025
HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development for infectious [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 38 - 2025
23/09/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 15 Septembre au 19 Septembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2025
23/09/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 15th to September 19th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]

Pages